Cardiovascular Diseases
"Cardiovascular Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
Descriptor ID |
D002318
|
MeSH Number(s) |
C14
|
Concept/Terms |
Cardiovascular Diseases- Cardiovascular Diseases
- Cardiovascular Disease
- Disease, Cardiovascular
- Diseases, Cardiovascular
|
Below are MeSH descriptors whose meaning is more general than "Cardiovascular Diseases".
Below are MeSH descriptors whose meaning is more specific than "Cardiovascular Diseases".
This graph shows the total number of publications written about "Cardiovascular Diseases" by people in this website by year, and whether "Cardiovascular Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 1 | 2 | 1995 | 1 | 1 | 2 | 1996 | 1 | 1 | 2 | 1997 | 1 | 3 | 4 | 1998 | 0 | 2 | 2 | 1999 | 6 | 0 | 6 | 2000 | 5 | 2 | 7 | 2001 | 3 | 3 | 6 | 2002 | 7 | 4 | 11 | 2003 | 14 | 6 | 20 | 2004 | 16 | 3 | 19 | 2005 | 20 | 4 | 24 | 2006 | 23 | 20 | 43 | 2007 | 28 | 11 | 39 | 2008 | 39 | 9 | 48 | 2009 | 29 | 15 | 44 | 2010 | 29 | 11 | 40 | 2011 | 44 | 22 | 66 | 2012 | 58 | 22 | 80 | 2013 | 50 | 14 | 64 | 2014 | 38 | 21 | 59 | 2015 | 57 | 18 | 75 | 2016 | 47 | 21 | 68 | 2017 | 44 | 14 | 58 | 2018 | 61 | 23 | 84 | 2019 | 75 | 23 | 98 | 2020 | 79 | 16 | 95 | 2021 | 58 | 12 | 70 | 2022 | 81 | 1 | 82 | 2023 | 61 | 2 | 63 | 2024 | 4 | 0 | 4 |
To return to the timeline, click here.
Below are the most recent publications written about "Cardiovascular Diseases" by people in Profiles.
-
Bares SH, Wu X, Tassiopoulos K, Lake JE, Koletar SL, Kalayjian R, Erlandson KM. Weight Gain After Antiretroviral Therapy Initiation and Subsequent Risk of Metabolic and Cardiovascular Disease. Clin Infect Dis. 2024 Feb 17; 78(2):395-401.
-
Abushamat LA, Schauer IE, Low Wang CC, Mitchell S, Herlache L, Bridenstine M, Durbin R, Snell-Bergeon JK, Regensteiner JG, Reusch JE. Rosiglitazone improves insulin resistance but does not improve exercise capacity in individuals with impaired glucose tolerance: A randomized clinical study. J Investig Med. 2024 Mar; 72(3):294-304.
-
Nicklas JM, Pyle L, Soares A, Leiferman JA, Bull SS, Tong S, Caldwell AE, Santoro N, Barbour LA. The Fit After Baby randomized controlled trial: An mHealth postpartum lifestyle intervention for women with elevated cardiometabolic risk. PLoS One. 2024; 19(1):e0296244.
-
Greenstein AS, Reusch JEB, Heagerty AM. Is it time to recommend cardiovascular protection for all? J Hypertens. 2024 Feb 01; 42(2):224-226.
-
Sen R, Caplan L, Danila MI. Cardiovascular disease in spondyloarthritis: a narrative review of risk factors and the effect of treatments. Curr Opin Rheumatol. 2024 Mar 01; 36(2):95-107.
-
Uffelman CN, Schmok JN, Campbell RE, Hartman AS, Olson MR, Anderson NL, Reisdorph NA, Tang M, Krebs NF, Campbell WW. Consuming Mushrooms When Adopting a Healthy Mediterranean-Style Dietary Pattern Does Not Influence Short-Term Changes of Most Cardiometabolic Disease Risk Factors in Healthy Middle-Aged and Older Adults. J Nutr. 2024 02; 154(2):574-582.
-
Kobo O, Cavender MA, Jensen TJ, Kuhlman AB, Rasmussen S, Verma S. Once-weekly semaglutide reduces the risk of cardiovascular events in people with type 2 diabetes and polyvascular disease: A post hoc analysis. Diabetes Obes Metab. 2024 Mar; 26(3):1129-1132.
-
Starling AP, Friedman C, Boyle KE, Adgate JL, Glueck DH, Allshouse WB, Calafat AM, Bloemsma LD, Dabelea D. Prenatal exposure to per- and polyfluoroalkyl substances and early childhood adiposity and cardiometabolic health in the Healthy Start study. Int J Obes (Lond). 2024 Feb; 48(2):276-283.
-
Lu Y, Liu Y, Dhingra LS, Caraballo C, Mahajan S, Massey D, Spatz ES, Sharma R, Rodriguez F, Watson KE, Masoudi FA, Krumholz HM. National Trends in Racial and Ethnic Disparities in Use of Recommended Therapies in Adults with Atherosclerotic Cardiovascular Disease, 1999-2020. JAMA Netw Open. 2023 Dec 01; 6(12):e2345964.
-
Bhasin S, Travison TG, Pencina KM, O'Leary M, Cunningham GR, Lincoff AM, Nissen SE, Lucia MS, Preston MA, Khera M, Khan N, Snabes MC, Li X, Tangen CM, Buhr KA, Thompson IM. Prostate Safety Events During Testosterone Replacement Therapy in Men With Hypogonadism: A Randomized Clinical Trial. JAMA Netw Open. 2023 Dec 01; 6(12):e2348692.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|